The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Forecasted Rise In Market Size Of The Zoonotic Disease Treatment Market During The Forecast Period?

The zoonotic disease treatment market has shown significant expansion in recent years. It is projected to increase from $42.51 billion in 2025 to $45.48 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.0%. This historical growth can be linked to frequent zoonotic disease transmission events, limited disease surveillance in animal populations, a high reliance on conventional antibiotics, an absence of coordinated animal and human health strategies, and increased human-animal interaction.

The zoonotic disease treatment market size is projected to experience substantial expansion in the coming years. This market is anticipated to reach $57.77 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.2%. Key drivers for this growth during the forecast period include advancements in zoonotic disease diagnostics and therapies, a greater embrace of “One Health” strategies, increased governmental investment in controlling zoonotic diseases, broader animal vaccination programs, and the growth of worldwide disease surveillance initiatives. Significant trends expected over the forecast period encompass a rising frequency of zoonotic disease outbreaks, a heightened emphasis on preventative care and prophylaxis, an increasing need for wide-ranging anti-infective treatments, the broadening of integrated animal and human health initiatives, and a focus on prompt diagnosis and swift treatment commencement.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15965&type=smp

Which Drivers Are Advancing The Zoonotic Disease Treatment Market Growth?

The increased demand for animal proteins is expected to propel the growth of the zoonotic disease treatment market going forward. Animal proteins are proteins derived from animal sources, such as meat, dairy, eggs, and fish, and contain all essential amino acids necessary for human health. The increased demand for animal proteins is due to the rising global population, higher income levels, urbanization, and growing awareness of the nutritional benefits of animal-based foods. Zoonotic disease treatments offer insights for managing diseases stemming from animal proteins, understanding transmission routes, developing effective therapies, and implementing preventive measures to mitigate public health risks. For instance, in March 2025, according to the Australian Bureau of Statistics (ABS) is an Australia-based official national statistical agency, meat and poultry products per capita increased by 2.3% compared with 2023-24. This reflects a clear rise in animal-based protein intake by weight in the national diet. Therefore, the increased demand for animal proteins is driving the growth of the zoonotic disease treatment market.

Zoonotic Disease Treatment Market Driver: Surge In Global Livestock Production Driving The Growth Of The Market Due To Rising Demand For Animal-Based Food Products

Growing global livestock production is expected to propel the growth of the zoonotic disease treatment market going forward. Livestock production refers to the systematic, human-managed breeding, raising, keeping, and utilization of domesticated animals (livestock) to generate food, fiber, labor, and other products for human consumption or use. Growing global livestock production is increasing due to the rising demand for animal-based food products driven by population growth and changing dietary preferences. Livestock production supports zoonotic disease treatment by serving as a critical interface for surveillance, research, and management of animal health, enabling early detection of pathogens, development of vaccines and therapeutics, and implementation of biosecurity practices that reduce transmission between animals and humans while strengthening integrated One Health responses. For instance, in July 2025, according to the official statistics, a UK-based government agencies, in 2024, the total value of livestock output in the UK was £20.1 ($23.69) billion, up £1.1 ($1.30) billion (+5.6%) compared with 2023. This growth was largely driven by higher prices and increased production in eggs, beef, and milk sectors. Therefore, growing global livestock production is driving the growth of the zoonotic disease treatment market.

How Is The Zoonotic Disease Treatment Market Distributed Across Key Segments?

The zoonotic disease treatment market covered in this report is segmented –

1) By Disease Type: Rabies, Tuberculosis, Leishmaniasis, Ebola Virus Disease, Other Disease Types

2) By Drug Class: Anti-Fungal, Anti-Bacterial, Antibiotics, Other Drug Classes

3) By Causative Agent: Bacteria, Virus, Nematode, Rodents, Ticks, Other Causative Agents

4) By Route Of Administration: Oral, Topical, Other Routes Of Administrations

5) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

Subsegments:

1) By Rabies: Post Exposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)

2) By Tuberculosis: Latent Tuberculosis Treatment, Active Tuberculosis Treatment

3) By Leishmaniasis: Visceral Leishmaniasis, Cutaneous Leishmaniasis, Mucocutaneous Leishmaniasis

4) By Ebola Virus Disease: Pre-Exposure Vaccination, Post-Exposure Treatment

5) By Other Disease Types: Zika Virus, Lassa Fever, Yellow Fever, Chikungunya

What Trends Are Influencing The Zoonotic Disease Treatment Market?

Major companies operating in the zoonotic disease treatment market are focused on investing in zoonotic disease treatment to enhance diagnostic capabilities and improving treatment protocols. This includes developing advanced diagnostic technologies, such as PCR kits, to facilitate quicker identification of zoonotic pathogens and implementing targeted therapeutic interventions. For instance, in October 2023, BioPerfectus, a China-based biotechnology company specializing in diagnostic solutions, launched the addition of thirteen new members to its Zoonotic Infectious Diseases Total PCR Solution. This enhancement aims to bolster its diagnostic capabilities for zoonotic diseases, which account for over 60% of known infectious diseases and 75% of emerging infections. The initiative is designed to improve health security preparedness and response, particularly as climate change facilitates the spread of infectious diseases to new regions. With these new products, the company aims to enable quicker diagnoses and better management of zoonotic infections, highlighting the importance of proactive public health measures.

Which Key Players Are Active In The Zoonotic Disease Treatment Market?

North America was the largest region in the zoonotic disease treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the zoonotic disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access The Complete Zoonotic Disease Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/zoonotic-disease-treatment-global-market-report

Which Region Accounts For The Highest Share Of The Zoonotic Disease Treatment Market?

North America was the largest region in the zoonotic disease treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the zoonotic disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Zoonotic Disease Treatment Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=15965&type=smp

Get in touch with us: